190 related articles for article (PubMed ID: 36795725)
1. TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population.
Yaghoobi A; Lord JS; Rezaiezadeh JS; Yekaninejad MS; Amini M; Izadi P
PLoS One; 2023; 18(2):e0281750. PubMed ID: 36795725
[TBL] [Abstract][Full Text] [Related]
2. Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses.
Rokni M; Heidari Nia M; Sarhadi M; Mirinejad S; Sargazi S; Moudi M; Saravani R; Rahdar S; Kargar M
Appl Biochem Biotechnol; 2022 Aug; 194(8):3507-3526. PubMed ID: 35386063
[TBL] [Abstract][Full Text] [Related]
3. A common TMPRSS2 variant has a protective effect against severe COVID-19.
David A; Parkinson N; Peacock TP; Pairo-Castineira E; Khanna T; Cobat A; Tenesa A; Sancho-Shimizu V; ; ; Casanova JL; Abel L; Barclay WS; Baillie JK; Sternberg MJ
Curr Res Transl Med; 2022 May; 70(2):103333. PubMed ID: 35104687
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt.
Elnagdy MH; Magdy A; Eldars W; Elgamal M; El-Nagdy AH; Salem O; Elmowafy MM; Elborsh OA; Elshafey AW; Kesba MM; Abdulgalil AE; Sobh A
Virol J; 2024 Jan; 21(1):27. PubMed ID: 38263160
[TBL] [Abstract][Full Text] [Related]
5. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
6. rs12329760 Polymorphism in Transmembrane Serine Protease 2 Gene and Risk of Coronavirus Disease 2019 Mortality.
Beheshti Shirazi SS; Sakhaee F; Sotoodehnejadnematalahi F; Zamani MS; Ahmadi I; Anvari E; Fateh A
Biomed Res Int; 2022; 2022():7841969. PubMed ID: 36457338
[TBL] [Abstract][Full Text] [Related]
7.
Abdelsattar S; Kasemy ZA; Ewida SF; Abo-Elsoud RAA; Zytoon AA; Abdelaal GA; Abdelgawad AS; Khalil FO; Kamel HFM
Br J Biomed Sci; 2022; 79():10238. PubMed ID: 35996506
[No Abstract] [Full Text] [Related]
8. Assessment of risk conferred by coding and regulatory variations of
Senapati S; Kumar S; Singh AK; Banerjee P; Bhagavatula S
J Genet; 2020; 99(1):. PubMed ID: 32661206
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population.
Kaidashev I; Izmailova O; Shlykova O; Kabaliei A; Vatsenko A; Ivashchenko D; Dudchenko M; Volianskyi A; Zelinskyy G; Koval T; Dittmer U
Acta Biomed; 2023 Feb; 94(1):e2023030. PubMed ID: 36786264
[TBL] [Abstract][Full Text] [Related]
10. Genetic association of TMPRSS2 rs2070788 polymorphism with COVID-19 case fatality rate among Indian populations.
Pandey RK; Srivastava A; Singh PP; Chaubey G
Infect Genet Evol; 2022 Mar; 98():105206. PubMed ID: 34995811
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
[TBL] [Abstract][Full Text] [Related]
12. Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
Zarubin A; Stepanov V; Markov A; Kolesnikov N; Marusin A; Khitrinskaya I; Swarovskaya M; Litvinov S; Ekomasova N; Dzhaubermezov M; Maksimova N; Sukhomyasova A; Shtygasheva O; Khusnutdinova E; Radzhabov M; Kharkov V
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375616
[TBL] [Abstract][Full Text] [Related]
13.
Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
Front Genet; 2021; 12():667231. PubMed ID: 33968142
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole-exome sequencing data in the Turkish population.
Duman N; Tuncel G; Bisgin A; Bozdogan ST; Sag SO; Gul S; Kiraz A; Balta B; Erdogan M; Uyanik B; Canbek S; Ata P; Geckinli BB; Arslan Ates E; Alavanda C; Yesim Ozdemir S; Sezer O; Ozgon GO; Gurkan H; Guler K; Boga I; Kaya N; Alemdar A; Sayan M; Dundar M; Ergoren MC; Temel SG
J Med Virol; 2022 Nov; 94(11):5225-5243. PubMed ID: 35811452
[TBL] [Abstract][Full Text] [Related]
15. Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors.
Fernández-de-Las-Peñas C; Arendt-Nielsen L; Díaz-Gil G; Gómez-Esquer F; Gil-Crujera A; Gómez-Sánchez SM; Ambite-Quesada S; Palomar-Gallego MA; Pellicer-Valero OJ; Giordano R
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360172
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in
Dieter C; de Almeida Brondani L; Lemos NE; Schaeffer AF; Zanotto C; Ramos DT; Girardi E; Pellenz FM; Camargo JL; Moresco KS; da Silva LL; Aubin MR; de Oliveira MS; Rech TH; Canani LH; Gerchman F; Leitão CB; Crispim D
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672770
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of relationship between TMPRSS2 p.(Val197Met) variant and COVID-19 susceptibility and severity.
Bashar NAS; Gohar NMA; Tantawy AA; Kamel MHM
BMC Infect Dis; 2024 Jan; 24(1):112. PubMed ID: 38254046
[TBL] [Abstract][Full Text] [Related]
18. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.
Singh H; Choudhari R; Nema V; Khan AA
Microb Pathog; 2021 Jan; 150():104621. PubMed ID: 33278516
[TBL] [Abstract][Full Text] [Related]
19. A variant in
Ravikanth V; Sasikala M; Naveen V; Latha SS; Parsa KVL; Vijayasarathy K; Amanchy R; Avanthi S; Govardhan B; Rakesh K; Kumari DS; Srikaran B; Rao GV; Reddy DN
Meta Gene; 2021 Sep; 29():100930. PubMed ID: 34075330
[TBL] [Abstract][Full Text] [Related]
20. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
